1h
Zacks.com on MSNIs Veeva (VEEV) a Buy as Wall Street Analysts Look Optimistic?Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a ...
16h
Hosted on MSNHere's Why Veeva Systems (VEEV) Gained But Lagged the Market TodayVeeva Systems (VEEV) closed the most recent trading day at $237.81, moving +0.26% from the previous trading session. This move lagged the S&P 500's daily gain of 0.67%. Meanwhile, the Dow experienced ...
Pharmaceutical software company Veeva Systems has sued Microsoft in California federal court, alleging Microsoft's Viva ...
Spire Wealth Management lowered its holdings in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 50.1% in the fourth ...
Veeva Systems' specialization in life sciences, strong balance sheet, and innovative culture position it well for long-term growth. See why VEEV stock is a Buy.
Buying $1000 In VEEV: If an investor had bought $1000 of VEEV stock 10 years ago, it would be worth $7,775.33 today based on ...
CENTRAL TRUST Co decreased its position in shares of Veeva Systems Inc. (NYSE:VEEV – Free Report) by 11.0% during the 4th ...
It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good ...
With Veeva RIM, Servier has a solution that enables quick adaptation to evolving EU regulatory demands. Veeva is partnering ...
Dan Rizzo, global head of Veeva Business Consulting, spoke with Pharmaceutical Executive about the state of product launches ...
Veeva Systems Inc. provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship ...
PLEASANTON, Calif., Jan. 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that more than 200 companies – including 17 of the top 20 biopharmas – use Veeva CTMS to execute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results